35 hours ago Dr. Berenson. Dr. Berenson has his private practice in West Hollywood, California and has specialized in the treatment of patients with multiple myeloma, MGUS, amyloidosis, Waldenstrom’s macroglobulinemia and metastatic bone disease as well as conducting research related to these disease both in the basic and clinical areas for more than 20 ... >> Go To The Portal
Dr. Berenson has his private practice in West Hollywood, California and has specialized in the treatment of patients with multiple myeloma, MGUS, amyloidosis, Waldenstrom’s macroglobulinemia and metastatic bone disease as well as conducting research related to these disease both in the basic and clinical areas for more than 20 years.
Dr. Berenson graduated from the University of California San Diego School of Medicine in 1977. He works in BEVERLY HILLS, CA and 2 other locations and specializes in Internal Medicine, Hematology/Oncology and Medical Oncology.
Dr. Berenson has authored nearly 300 peer-reviewed publications and contributed to multiple book chapters.
Myeloma is a marrow-based form of bone cancer in which the bone marrow is oversupplied with plasma cells, which is a type of white cell. Plasma cells normally make lots of different kinds of antibodies and make up only about half a percent of your marrow. With myeloma, they make a lot larger of a percentage and they’re all one type and make one antibody.
The drugs that strengthen them are called bisphosphonates or anti-RANKL antibodies from companies like AmGen.
There are a lot of new, more targeted treatments with antibodies or pathway inhibitors. Pathway inhibitors stop pathways that grow myeloma or makes the soil in which the myeloma grows less hospitable. It makes it like a barren desert instead of fertile ground for the myeloma.
My name is James Berenson. I’ve been working in oncology for nearly 40 years. I’ve been working in the myeloma arena for about 35. I run a practice. I see about 125 myeloma patients a week.
If your doctor doesn’t want to look into treatment options that make you more comfortable, find someone who is willing. You don’t have to stick with that doctor. You don’t have to go with their approach.
We have a non-profit called The Institute for Myeloma and Bone Cancer Research. We have spun off some intellectual property into a biotech company called OncoTracker. We’re basically a four-ring circus.
Last but not least, when a patient has myeloma, the antibody their plasma is making can be toxic to the kidneys. People often will get kidney problems from the deposition of the protein. That can lead to loss of kidney function.
Dr. Berenson graduated from the University of California San Diego School of Medicine in 1977. He works in BEVERLY HILLS, CA and 2 other locations and specializes in Internal Medicine, Hematology/Oncology and Medical Oncology. Dr. Berenson is affiliated with Cedars-Sinai Medical Center.
Please verify insurance information directly with your doctor’s office as it may change frequently.